19 studies found for:    Open Studies | "Liver Cirrhosis, Biliary"
Show Display Options
Rank Status Study
1 Unknown  Identification of the Genetic Variants Responsible for Primary Biliary Cirrhosis (PBC)
Conditions: Liver Cirrhosis, Biliary;   Biliary Cirrhosis, Primary
Intervention:
2 Recruiting Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Other: conventional plus UC-MSC treatment;   Other: Conventional plus placebo treatment
3 Unknown  Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Biological: Biological: mesenchymal stem cell;   Drug: ursodeoxycholic acid
4 Not yet recruiting Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Biological: abatacept
5 Unknown  Family Studies in Primary Biliary Cirrhosis (PBC)
Condition: Biliary Cirrhosis, Primary
Intervention:
6 Recruiting Genetic Epidemiology of Primary Biliary Cirrhosis (PBC)
Condition: Primary Biliary Cirrhosis
Intervention: Genetic: Genetic Analysis
7 Recruiting High-protein High-fiber Diet in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Dietary Supplement: High protein high fiber diet
8 Recruiting Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Biological: NGM282;   Biological: Placebo
9 Recruiting Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis
Conditions: Primary Biliary Cirrhosis;   PBC
Interventions: Drug: LUM001;   Drug: Placebo;   Drug: Ursodeoxycholic Acid
10 Recruiting Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Biological: NGM282
11 Recruiting Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC)
Condition: Primary Biliary Cirrhosis
Interventions: Drug: budesonide;   Drug: budesonide placebo
12 Unknown  Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
Conditions: Hepatitis C;   Hepatitis B;   Autoimmune Hepatitis;   Liver Cirrhosis, Biliary;   Cholangitis, Sclerosing
Intervention:
13 Not yet recruiting Pilot Study of FFP104 Dose Escalation in PBC Subjects
Condition: Primary Biliary Cirrhosis
Intervention: Drug: FFP104
14 Recruiting Evaluation of Patients With Liver Disease
Conditions: Biliary Liver Cirrhosis,;   Hemochromatosis;   Hepatitis;   Hepatolenticular Degeneration;   Liver Disease
Intervention:
15 Recruiting A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus
Condition: Cholestasis, Intrahepatic
Interventions: Drug: GSK2330672;   Drug: Placebo;   Drug: Ursodeoxycholic acid
16 Recruiting Biliary Excretion of Conjugated Bile Acids in Humans Measured by 11C-cholylsarcosine PET/CT
Conditions: Cholestatic Liver Disorders;   Primary Sclerosing Cholangitis;   Primary Biliary Cirrhosis
Interventions: Drug: 11C-CSar;   Drug: ICG
17 Recruiting Phase 3 Study of Bezafibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis
Condition: PBC
Interventions: Drug: Bezafibrate;   Drug: placebo
18 Recruiting Be the Bridge Between Researchers and a Cure (GVHD, ALS, Hepatitis B, Alzheimer's Disease, Leukemia, and More)
Condition: All Diagnosed Health Conditions
Intervention:
19 Unknown  Sulfation of Bile Acids as a Biomarker for Hepatobiliary Diseases
Condition: Hepatobiliary Diseases
Intervention:

Indicates status has not been verified in more than two years